Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May:177:104777.
doi: 10.1016/j.antiviral.2020.104777. Epub 2020 Mar 23.

Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication

Affiliations

Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication

Qilan Li et al. Antiviral Res. 2020 May.

Abstract

The Hepatitis B Virus (HBV) ribonuclease H (RNaseH) is a promising but unexploited drug target. Here, we synthesized and analyzed a library of 57 amide-containing α-hydroxytropolones (αHTs) as potential leads for HBV drug development. Fifty percent effective concentrations ranged from 0.31 to 54 μM, with selectivity indexes in cell culture of up to 80. Activity against the HBV RNaseH was confirmed in semi-quantitative enzymatic assays with recombinant HBV RNaseH. The compounds were overall poorly active against human ribonuclease H1, with 50% inhibitory concentrations of 5.1 to >1,000 μM. The αHTs had modest activity against growth of the fungal pathogen Cryptococcus neoformans, but had very limited activity against growth of the Gram - bacterium Escherichia coli and the Gram + bacterium Staphylococcus aureus, indicating substantial selectivity for HBV. A molecular model of the HBV RNaseH templated against the Ty3 RNaseH was generated. Docking the compounds to the RNaseH revealed the anticipated binding pose with the divalent cation coordinating motif on the compounds chelating the two Mn++ ions modeled into the active site. These studies reveal that that amide αHTs can be strong, specific HBV inhibitors that merit further assessment toward becoming anti-HBV drugs.

Keywords: Hepatitis B Virus; Molecular modeling; Ribonuclease H; α-Hydroxytropolones.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Structure and synthesis of α-hydroxytropolones (αHTs).
A. Representative examples of natural product and synthetic αHTs with antiviral activity against HBV, along with their 50% effective concentration values for viral replication inhibition and selectivity indexes (SI) based on toxicity in HepG2-DES19 cells. B. Final-step amidation sequence used to create a library of amide-containing αHTs.
Fig 2.
Fig 2.. Example HBV replication inhibition and CC50 experiments.
Left, Replication inhibition. Representative assays are shown. Values are the average ± standard deviation from multiple assays. Black, plus-polarity DNA; gray, minus-polarity DNA. Right, Cytotoxicity. Representative MTS assays are shown. Values are the average ± standard deviation from multiple assays. Representative assays with the nucleoside analog Lamivudine are shown for context.
Fig. 3.
Fig. 3.. HBV RNaseH homology model and in silico docking of αHTs to the HBV RNaseH active site.
A. Homology model for the HBV RNaseH. Purple spheres represent Mn++ ions modeled into the active site. B. 390 (green) and 404 (magenta) docked into the HBV RNaseH active site. C. 390 (green) and 120 (red) docked into the active site. D. Alternative binding pose of 920. The active site Mn++ ions used during docking are shown as blue spheres near the upper left of panels B-D.
Fig. 4.
Fig. 4.. Nitrobenzoxadiazol derivatives used to test the alternative binding pose of 390.
IC50 values are against the HBV RNaseH.

References

    1. Agyemang NB, Kukla CR, Edwards TC, Li Q, Langen MK, Schaal A, Franson AD, Casals AG, Donald KA, Yu AJ, Donlin MJ, Morrison LA, Tavis JE, Murelli RP, 2019. Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profile. RSC Advances 9, 34227–34234. - PMC - PubMed
    1. Berkowitz AJ, Abdelmessih RG, Murelli RP, 2018. Amidation Strategy for Final-Step alpha-Hydroxytropolone Diversification. Tetrahedron Lett 59, 3026–3028. - PMC - PubMed
    1. Block TM, Gish R, Guo H, Mehta A, Cuconati A, Thomas London W, Guo JT, 2013. Chronic hepatitis B: What should be the goal for new therapies? Antiviral Res 98, 27–34. - PMC - PubMed
    1. Cai CW, Lomonosova E, Moran EA, Cheng X, Patel KB, Bailly F, Cotelle P, Meyers MJ, Tavis JE, 2014. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity. Antiviral Res 108, 48–55. - PMC - PubMed
    1. Cao F, Orth C, Donlin MJ, Adegboyega P, Meyers MJ, Murelli RP, Elagawany M, Elgendy B, Tavis JE, 2018. Synthesis and Evaluation of Troponoids as a New Class of Antibiotics. ACS Omega 3, 15125–15133. - PMC - PubMed

Publication types

LinkOut - more resources